{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:44Z","timestamp":1787004824062,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1053\/j.jvca.2024.05.015","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:03:44Z","timestamp":1715954624000},"page":"1875-1881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Factor Eight Inhibitor Bypassing Activity as First-line Therapy for Coagulopathy in Cardiac Surgery"],"prefix":"10.1053","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-6633","authenticated-orcid":false,"given":"Hyungjoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Manetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3981-3194","authenticated-orcid":false,"given":"Pey-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1053\/j.jvca.2024.05.015_bib0001","first-page":"2s","article-title":"A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery","volume":"48","author":"Despotis","year":"2008","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2024.05.015_bib0002","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jtcvs.2013.10.070","article-title":"Universal definition of perioperative bleeding in adult cardiac surgery","volume":"147","author":"Dyke","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2024.05.015_bib0003","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/jth.15195","article-title":"Managing the coagulopathy associated with cardiopulmonary bypass","volume":"19","author":"Bartoszko","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2024.05.015_bib0004","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12471-016-0936-1","article-title":"Benchmarking the use of blood products in cardiac surgery to stimulate awareness of transfusion behaviour: Results from a four-year longitudinal study","volume":"25","author":"Brouwers","year":"2017","journal-title":"Neth Heart J"},{"key":"10.1053\/j.jvca.2024.05.015_bib0005","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1053\/j.jvca.2021.03.011","article-title":"STS\/SCA\/AmSECT\/SABM update to the clinical practice guidelines on patient blood management","volume":"35","author":"Tibi","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.05.015_bib0006","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1053\/j.jvca.2019.12.049","article-title":"Intraoperative plasma transfusion volumes and outcomes in cardiac surgery","volume":"34","author":"Smith","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.05.015_bib0007","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jtcvs.2013.11.020","article-title":"Safety and efficacy of prothrombin complex concentrates for the treatment of coagulopathy after cardiac surgery","volume":"147","author":"Song","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2024.05.015_bib0008","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/14779072.2022.2074838","article-title":"The use of FEIBA for refractory bleeding in cardiac surgery - A systematic review","volume":"20","author":"Khoury","year":"2022","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1053\/j.jvca.2024.05.015_bib0009","doi-asserted-by":"crossref","first-page":"e12838","DOI":"10.1002\/rth2.12838","article-title":"Factor eight inhibitor bypassing activity for refractory bleeding in coronary artery bypass grafting: A propensity-matched analysis","volume":"6","author":"Pupovac","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1053\/j.jvca.2024.05.015_bib0010","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1111\/trf.17117","article-title":"Factor eight inhibiting bypass activity for refractory bleeding in acute type A aortic dissection repair: A propensity-matched analysis","volume":"62","author":"Pupovac","year":"2022","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2024.05.015_bib0011","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/hae.12873","article-title":"Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA(\u00ae) in prophylactic therapy","volume":"22","author":"Varadi","year":"2016","journal-title":"Haemophilia"},{"key":"10.1053\/j.jvca.2024.05.015_bib0012","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1538-7836.2004.00944.x","article-title":"Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity","volume":"2","author":"Aledort","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2024.05.015_bib0013","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"key":"10.1053\/j.jvca.2024.05.015_bib0014","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1053\/j.jvca.2024.05.015_bib0015","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1540-8191.2008.00686.x","article-title":"Factor eight inhibitor bypassing activity (FEIBA) for refractory bleeding in cardiac surgery: Review of clinical outcomes","volume":"23","author":"Balsam","year":"2008","journal-title":"J Card Surg"},{"key":"10.1053\/j.jvca.2024.05.015_bib0016","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(07)61199-4","article-title":"Coagulation factor concentrates: Past, present, and future","volume":"370","author":"Key","year":"2007","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2024.05.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.3936","article-title":"Comparison of 4-factor prothrombin complex concentrate with frozen plasma for management of hemorrhage during and after cardiac surgery: A randomized pilot trial","volume":"4","author":"Karkouti","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.jvca.2024.05.015_bib0018","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bja.2018.02.017","article-title":"Use of prothrombin complex concentrate for management of coagulopathy after cardiac surgery: A propensity score matched comparison to plasma","volume":"120","author":"Fitzgerald","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2024.05.015_bib0019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13054-015-1172-6","article-title":"Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery","volume":"20","author":"Cappabianca","year":"2016","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.05.015_bib0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.xjon.2023.01.006","article-title":"Blood transfusion in aortic root surgery impairs midterm survival","volume":"13","author":"Dalal","year":"2023","journal-title":"JTCVS Open"},{"key":"10.1053\/j.jvca.2024.05.015_bib0021","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0041-1729860","article-title":"Transfusion in elective proximal aortic reconstruction: where do we currently stand?","volume":"30","author":"Pupovac","year":"2021","journal-title":"Int J Angiol"},{"key":"10.1053\/j.jvca.2024.05.015_bib0022","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1053\/j.jvca.2014.05.025","article-title":"Dose-dependent effects of intraoperative low volume red blood cell transfusions on postoperative outcomes in cardiac surgery patients","volume":"28","author":"Yu","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.05.015_bib0023","first-page":"e32","article-title":"Transfusion of red blood cells, fresh frozen plasma, or platelets is associated with mortality and infection after cardiac surgery in a dose-dependent manner","volume":"130","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2024.05.015_bib0024","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.athoracsur.2021.06.061","article-title":"Number and type of blood products are negatively associated with outcomes after cardiac surgery","volume":"113","author":"Ad","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2024.05.015_bib0025","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/trf.14561","article-title":"Platelet transfusion is not associated with increased mortality or morbidity in patients undergoing cardiac surgery","volume":"58","author":"Ninkovic","year":"2018","journal-title":"Transfusion"},{"key":"10.1053\/j.jvca.2024.05.015_bib0026","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1378\/chest.06-3048","article-title":"Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients","volume":"131","author":"Khan","year":"2007","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2024.05.015_bib0027","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.athoracsur.2023.02.054","article-title":"Association of perioperative cryoprecipitate transfusion and mortality after cardiac surgery","volume":"116","author":"Hinton","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2024.05.015_bib0028","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/bja\/aeu158","article-title":"Cryoprecipitate therapy","volume":"113","author":"Nascimento","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2024.05.015_bib0029","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/CCM.0000000000002948","article-title":"Contemporary risk factors and outcomes of transfusion-associated circulatory overload","volume":"46","author":"Roubinian","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.05.015_bib0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/MBC.0000000000000243","article-title":"Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass","volume":"26","author":"Percy","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1053\/j.jvca.2024.05.015_bib0031","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1213\/ANE.0000000000000689","article-title":"An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery","volume":"121","author":"Ortmann","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2024.05.015_bib0032","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1053\/j.jvca.2014.04.015","article-title":"Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery","volume":"28","author":"Rao","year":"2014","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024003240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024003240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T19:59:36Z","timestamp":1724356776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077024003240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1053077024003240"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2024.05.015","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factor Eight Inhibitor Bypassing Activity as First-line Therapy for Coagulopathy in Cardiac Surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2024.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}